My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
February 2011
Policy and Advocacy
President’s FY 2012 Budget Strengthens ID Programs
But cuts proposed by House lawmakers threaten public health here and abroad

President Obama’s budget for the 2012 fiscal year (FY) makes needed investments to strengthen key U.S. public health and research initiatives, in addition to strengthening the country’s capacity to prevent, diagnose, and treat an increasing number of ID threats, according to IDSA’s analysis. However, cuts proposed by the House of Representatives for the remainder of FY2011 would threaten these important gains in public health.

Released in February, the president’s budget supports critically needed ID research at the National Institutes of Health (NIH), especially at the National Institute for Allergy and Infectious Diseases (NIAID), according to an IDSA statement in response to the budget. An analysis published earlier this month in the New England Journal of Medicine underscores the important benefits this funding has on improving public health.

The president’s proposal includes investments for critical ID programs at the Centers for Disease Control and Prevention (CDC) and for the Food and Drug Administration (FDA)’s much-needed regulatory science and countermeasures initiatives. The Society also welcomed $765 million proposed for the Biomedical Advanced Research and Development Authority (BARDA), including funding to provide financial and business support to companies that develop new antibiotics and other medical countermeasures.

These critical investments in public health would be undercut by shortsighted spending cuts for the remainder of FY2011 proposed in February by lawmakers in the House.

In a joint statement, IDSA, the HIV Medicine Association (HIVMA), and the Center for Global Health Policy highlighted the danger to public health here and around the world posed by the drastic proposed cuts in critical funding for CDC, NIH, FDA, the Health Resources and Services Administration, the United States Agency for International Development, and other agencies. In an e-mail, IDSA also urged members to contact their members of Congress to communicate the value of funding ID and HIV-related research and public health programs and the dire consequences of these cuts.

For additional information about the president’s funding proposals for domestic HIV/AIDS funding and global HIV and tuberculosis, please see press releases issued by HIVMA and the Center for Global Health Policy (PDF).
How useful is this article?

< Previous Article | Next Article >

Post a comment

Your name:

Your comment:

Patient Care and Science
NIAID Seeks Input on ID Clinical Trials Network
EIN Update: Antimicrobial Prophylaxis and Neurosurgical Procedures
U.S. Supreme Court Upholds Vaccine Injury Compensation Program
ACIP Urges Pertussis Vaccination for Health Care Workers
Drug Approvals, Recalls, Adverse Events Update
2011 Immunization Schedules Now Online
Clinical Practice Management
Electronic Health Records and “Meaningful Use” Incentives
“Ask the Coder” Answers CPT Questions
Physician Compensation Survey Now Available
Global ID
Science Speaks Blog to Host Series on Medical Male Circumcision
What Lies Ahead for Global AIDS and TB: A Discussion with Gates Foundation Leaders
Policy and Advocacy
President’s FY 2012 Budget Strengthens ID Programs
IDSA Weighs in on Health Care Reform Provisions
Your Colleagues
Call for Nominations for the 2011 IDSA Election
Members on the Move
Welcome, New Members!
Education & Resources
IDSA Influenza Conference Available Online, with CME Credit
Antimicrobial Resistance CME Activity Available Online
Sign Up for Alerts for IDSA Journals
Top Stories
From the President: Nurturing the Next Generation of ID Physicians and Scientists
Updated IDSA/ESCMID Guideline for Uncomplicated Cystitis
IDSA Journal Club
IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add '' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.